REDOX LIMITED — AGM Information 2025

Sep 4, 2025

==> picture [201 x 51] intentionally omitted <==

REDOX LIMITED NOTICE OF MEETING FOR 2025 ANNUAL GENERAL MEETING

_____________________

REDOX LIMITED (COMPANY) ABN 92 000 762 345

Redox Limited Notice of Meeting 2025

Redox Limited 2025 Notice of Annual General Meeting

Notice is given that the 2025 Annual General Meeting (“AGM”) of Redox Limited (Redox or the Company) will be held at Swissotel Sydney, 68 Market Street, Sydney, NSW 2000 on Wednesday, 8 October 2025 at 11.00am (AEDT) (the Meeting).

The Meeting will be held as a hybrid meeting, meaning Shareholders can also view and participate in the Meeting via the online portal at: https://meetnow.global/MSTNXNQ. Further information on how to attend and participate virtually is available at: www.computershare.com.au/virtualmeetingguide

Items of Business

1. Financial Report, Directors, Report, and Auditor's Report:

To receive and consider the Financial Report of the Company and its controlled entities and the Reports of the Directors and Auditor for the year ended 30 June 2025.

Note: there is no requirement for shareholders to approve these reports.

2. Adoption of the Remuneration Report:

To consider and if thought fit, to pass the following as an ordinary resolution:

That the Remuneration Report for the year ended 30 June 2025 be adopted.

Note: The vote on this resolution is advisory only and does not bind the Directors or the Company. A voting exclusion statement applies to this resolution (see the notes relating to voting).

3. Re-election of Director:

To consider, and if appropriate, pass the following ordinary resolution:

That Mary Verschuer who retires by rotation and being eligible, is re-elected as a Director of the Company.

Note: Information about Mary Verschuer and the re-election under this Item 3 is available in the Explanatory Memorandum.

4. Grant of Performance Rights to Executive Directors:

4.1 Raimond Coneliano, CEO and Managing Director

To consider, and if thought fit, to pass the following resolution as an ordinary resolution:

That approval be given for all purposes, including ASX Listing Rule 10.14, for the grant of performance rights to CEO and Managing Director, Raimond Coneliano, on the terms described in the Explanatory Memorandum to this Notice of Meeting.

Note: A voting exclusion statement applies to this resolution (see the notes relating to voting).

4.2 Renato Coneliano, Marketing Director (Executive Director)

To consider, and if thought fit, to pass the following resolution as an ordinary resolution:

That approval be given for all purposes, including ASX Listing Rule 10.14, for the grant of performance rights to Marketing Director (Executive Director), Renato Coneliano, on the terms described in the Explanatory Memorandum to this Notice of Meeting.

Note: A voting exclusion statement applies to this resolution (see the notes relating to voting).

Redox Limited Notice of Meeting 2023

Page 1

109349848

4.3 Richard Coneliano, Chief Operating Officer (Alternate Director)

To consider, and if thought fit, to pass the following resolution as an ordinary resolution:

That approval be given for all purposes, including ASX Listing Rule 10.14, for the grant of performance rights to Chief Operating Officer (Alternate Director), Richard Coneliano, on the terms described in the Explanatory Memorandum to this Notice of Meeting.

Note: A voting exclusion statement applies to this resolution (see the notes relating to voting).

The notes relating to voting and AGM participation, and the Explanatory Memorandum form part of this Notice of Meeting.

By Order of the Board

Erika Jasarevic Company Secretary

8 September 2025

Redox Limited Notice of Meeting 2023

Page 2

109349848

Notes Relating to Voting and AGM Participation

How to Participate in the 2025 AGM

The Company will hold its AGM on Wednesday 8 October 2025, beginning at 11am (AEDT). The AGM will be held as a hybrid meeting, which means shareholders can attend and participate online or in person. Details regarding how to attend the AGM are set out below.

Attending the Meeting in Person and Online

If you are attending the Meeting in person, you must register at the Meeting. The registration desks will be open from 10:00am (AEDT) and we ask that you arrive at least 30 minutes before proceedings start to allow sufficient time to complete registration.

If you are attending online you will need a desktop, mobile or tablet device with internet access. We recommend that you log in and register from 10.30am (AEDT). To participate in the Meeting:

• a. Log in by entering the following URL: https://meetnow.global/MSTNXNQ on your Click on ‘Join Meeting Now’.

• b. Enter your SRN/HIN. Proxyholders will need to contact Computershare on +61 3 9415 4024 one hour prior to the meeting to obtain their unique email invitation link.

• c. Enter your postcode registered to your holding if you are an Australian shareholder. If you are an overseas shareholder select the country of your registered holding from the drop-down list.

• d. Accept the Terms and Conditions and ‘Click Continue’.

If you attend online, you can view the Meeting live, ask questions verbally or via a live text facility and cast votes at the appropriate times while the Meeting is in progress.

More information about how to use the online platform is available on the Online Meeting Guide available at: www.computershare.com.au/virtualmeetingguide

The Meeting will also be webcast live at https://meetnow.global/MSTNXNQ.

Entitlement to Vote

In accordance with Regulation 7.11.37 of the Corporations Regulations 2001 (Cth), the Board has determined that persons who are registered holders of shares in the Company as at 7:00 pm AEDT on Monday, 6 October 2025 will be entitled to attend and vote at the Meeting as a shareholder. Share transfers registered after that time will be disregarded in determining entitlements to attend and vote at the Meeting.

If more than one joint holder of shares is present at the Meeting (whether personally, by proxy or by attorney or by representative) and tenders a vote, only the vote of the joint holder whose name appears first on the register will be counted.

Voting will be conducted by way of a poll, whereby shareholders have one vote for every fully paid ordinary share held (subject to the restrictions on voting referred to below).

Redox Limited Notice of Meeting 2023

Page 3

109349848

Voting Exclusions

Item 2 (Adoption of Remuneration Report): The Company will disregard any votes cast on Item 2:

• by or on behalf of a member of the Company’s key management personnel (KMP) named in the Company’s remuneration report for the year ended 30 June 2025 or their closely related parties, regardless of the capacity in which the vote is cast; or

• as a proxy by a person who is a member of the Company’s KMP at the date of the AGM or their closely related parties,

unless the vote is cast as proxy for a person entitled to vote on Item 2:

• in accordance with a direction as to how to vote on the proxy form; or

• by the Chairman of the meeting pursuant to an express authorization to exercise the proxy even though Item 2 is connected with the remuneration of the Company’s KMP.

Items 4.1, 4.2 and 4.3 (Grant of Performance Rights to the Executive Directors): The Company will disregard any votes cast on Items 4.1, 4.2 and 4.3:

• in favour of the Items by, or on behalf of, Mr Raimond Coneliano, Mr Renato Coneliano, and Mr Richard Coneliano, and any of their associates, regardless of the capacity in which the vote is cast; or

• as a proxy by a person who is a member of the Company’s KMP at the date of the meeting or their closely related parties,

unless the vote is cast on Items 4.1, 4.2 or 4.3:

• as proxy or attorney for a person entitled to vote on the resolution in accordance with a direction given to the proxy or attorney to vote on the resolution in that way; or

• as proxy for a person entitled to vote on the resolution by the Chairman of the meeting pursuant to an express authorisation to exercise the proxy as the Chairman of the meeting decides, even though the resolution is connected with the remuneration of a member of the Company’s KMP; or

• by a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf of a beneficiary provided the following conditions are met:

• the beneficiary provides written confirmation to the holder that the beneficiary is not excluded from voting and is not an associate of a person excluded from voting on the resolution; and

• the holder votes on the resolution in accordance with directions given by the beneficiary to the holder, to vote in that way.

Proxies

A shareholder entitled to attend, and vote has a right to appoint a proxy to attend and vote instead of the shareholder. A proxy need not be a shareholder and can be either an individual or a body corporate. A shareholder can appoint a proxy by completing and returning a proxy form (see notes below relating to voting, and the proxy form). A shareholder that is entitled to cast 2 or more votes may appoint 2 proxies and may specify the proportion or number of votes each proxy is appointed to exercise. If no proportion or number is specified, each proxy may exercise half of the shareholder's votes.

If you wish to indicate how your proxy should vote, please mark the appropriate boxes on the proxy form. If you do not direct your proxy how to vote on a particular item of business, you are authorising your proxy to vote as they decide, subject to any applicable voting exclusions.

Members of the Company's KMP (which includes each of the Directors) and their closely related parties (which includes spouses and dependents) will not be able to vote as proxy on Items 2 , 4 . 1 , 4 . 2 a n d 4 . 3 unless you direct them how to vote or the Chairman of the Meeting is your proxy. If you intend to appoint a member of the KMP (such as one of the Directors) as your proxy, you should ensure that you direct that person how to vote on Items 2, 4.1, 4.2 and 4.3.

Redox Limited Notice of Meeting 2023

Page 4

109349848

On a poll if a shareholder has appointed a proxy (other than the Chairman of the Meeting), and the appointment of the proxy specifies the way the proxy is to vote on the resolution and that shareholder's proxy is either not recorded as attending the Meeting or does not vote on the resolution, the Chairman of the Meeting will, before voting on the resolution closes, be taken to have been appointed as the proxy for the shareholder for the purposes of voting on that resolution and must vote in accordance with the written direction of that shareholder.

Where the Chairman of the Meeting is appointed, or is taken to be appointed, as your proxy and you have not specified the way in which the Chairman should vote on Items 2, 4.1, 4.2 and 4.3, then by completing and submitting the proxy form, you are expressly authorizing the Chairman of the Meeting to exercise the proxy as he decides notwithstanding that these Items are connected with the remuneration of the Company’s KMP

The Chairman of the Meeting intends to vote all available proxies in favour of each resolution.

Proxy Form

If you wish to appoint a proxy to act on your behalf, please complete the proxy form. To be effective the proxy form must be received no later than 11.00am (AEDT) on Monday, 6 October 2025 at:

Online

www.investorvote.com.au using your secure access information.

Mail: Computershare Investor Services Pty Limited GPO Box 242, Melbourne VIC 3001, Australia Fax 1800 783 447 (in Australia) or +61 3 9473 2555 (outside Australia)

Redox Limited Notice of Meeting 2023 Page 5

109349848

Corporate Representatives

A body corporate that is a shareholder, or which has been appointed as a proxy, may appoint an individual to act as its representative at the Meeting. The appointment must comply with the requirements of section 250D of the Corporations Act. The representative should provide evidence of his or her appointment, including any authority under which it has been signed, prior to the commencement of the Meeting unless it has previously been given to the Company.

Voting by Attorney

A shareholder entitled to attend and vote may appoint an attorney to act on his or her behalf at the Meeting. An attorney may but need not be a member of the Company.

An attorney may not vote at the Meeting unless the instrument appointing the attorney, and the authority under which the instrument is signed or a certified copy of the authority, are received by the Company in the same manner, and by the same time, as outlined above for proxy forms.

Questions for the Company

On the day of the Meeting, shareholders will have a reasonable opportunity to comment and ask questions in person, and via the online platform at https://meetnow.global/MSTNXNQ. More detailed information on how to ask questions during the Meeting via the online platform is provided in the Online Meeting Guide available at: www.computershare.com.au/virtualmeetingguide.

Shareholders may also submit written questions to the Company prior to the Meeting by 5.00pm (AEDT), Tuesday 30 September 2025. Please send any written questions to: erika.jasarevic@redox.com The Chairman of the Meeting will endeavor to address the key questions raised during the Meeting. However, there may not be sufficient time available at the Meeting to address all questions raised. Please note that individual responses will not be sent to shareholders.

Technical Difficulties

Technical difficulties may arise during the Meeting. The Chairman of the Meeting has discretion as to whether and how the Meeting should proceed if a technical difficulty arises. In exercising their discretion, the Chairman of the Meeting will have regard to the number of shareholders impacted and the extent to which participation in the business of the meeting is affected. Where they consider it appropriate, the Chairman of the Meeting may continue to hold the Meeting and transact business, including conducting a poll and voting in accordance with valid proxy instructions. For this reason, shareholders are encouraged to lodge a directed proxy by 11.00am (AEDT) on Monday, 6 October 2025, even if they plan to attend the Meeting online or in person.

Shareholders should monitor the Company's website and ASX announcements where updates will be provided if it becomes necessary or appropriate to make alternative arrangements for the holding or conducting of the Meeting.

Redox Limited Notice of Meeting 2023

Page 6

109349848

Explanatory Memorandum

This Explanatory Memorandum has been prepared to help shareholders understand the Items of Business at the forthcoming AGM .

Item 1: Annual Financial Report, Directors' Report, and Auditor's Report

The Corporations Act requires:

• the reports of the Directors and Auditor; and

• the annual Financial Report, including the Financial Statements of the Company for the year ended June 2025,

to be laid before the Meeting. Neither the Corporations Act nor the Company's Constitution requires a vote of shareholders on the reports or statements. However, shareholders will be given an opportunity to raise questions or comments on the management of the Company.

Also, a reasonable opportunity will be given to shareholders at the Meeting to ask the Company's Auditor questions relevant to the conduct of the audit, the preparation and content of the Auditor's Report, the accounting policies adopted by the Company in relation to the preparation of the financial statements and the independence of the Auditor in relation to the conduct of the audit.

Item 2: Adoption of Remuneration Report

The Remuneration Report on pages 32-42 of the Company's Annual Report sets out the remuneration policies of the Company and reports on the remuneration arrangements in place for the Company's KMP during the year ended 30 June 2025 (FY25 Remuneration Report). Shareholders will have a reasonable opportunity at the Meeting to ask questions about or make comments on the Remuneration Report.

As prescribed by the Corporations Act, the vote on the adoption of the Remuneration Report is advisory only and does not bind the Directors or the Company. However, the Board will take the outcome of the vote and discussion at the Meeting into account in setting the remuneration policy for future years.

A voting exclusion statement applies to the resolution of Item 2, which is set out in the notes relating to voting.

Recommendation: The Board recommends that shareholders vote in favour of the adoption of the Remuneration Report.

Item 3: Re-election of Mary Verschuer

The ASX Listing Rules require Redox to hold an election of directors at each AGM. In accordance with rule 8.1 of the Company's Constitution, Mary Verschuer will retire from office at the conclusion of the Meeting and, being eligible offers herself for re-election at the Meeting.

==> picture [110 x 138] intentionally omitted <==

Mary has significant experience in executive leadership roles with responsibility for manufacturing, supply chain management and sales and marketing.

Mary currently serves as Non-Executive Director and Chair on the board of ASXlisted MaxiPARTS.

Mary previously served on the board of ASX-listed Nuplex, a leading global resins business, Forestry Corp of NSW as Audit and Risk Chair and as President of the Infants Home.

Mary’s key qualifications include a Bachelor of Applied Science (Chemistry) from UTS, a Master of Science and Society from UNSW, a Master of Business Administration from Macquarie University, and a Master of Arts (Research Methods) from Macquarie University.

Recommendation: The Board (with Mary abstaining) recommends that shareholders vote in favour of the reelection of Mary Verschuer.

Redox Limited Notice of Meeting 2023

Page 7

109349848

.

Items 4.1, 4.2 and 4.3: Grant of Performance Rights to Executive Directors

ASX Listing Rule 10.14 requires the Company to obtain Shareholder approval for the issue of securities to a Director under an employee incentive scheme. The Company is seeking Shareholder approval for the proposed grant of performance rights under the Performance Rights Plan (Plan) to the following Executive Directors (together, the Executive Directors):

• Raimond Coneliano, CEO and Managing Director;

• Renato Coneliano, Marketing Director (Executive Director); and

• Richard Coneliano, Chief Operating Officer (Alternate Director).

The Company issues performance rights under its long-term incentive plan (LTIP) to incentivise executives to manage the business in a way that drives sustainable long-term growth and shareholder value. Performance rights will only vest if the specific, long term performance hurdle attached to the performance rights is met. The Company uses performance rights because they create share price alignment between executives and ordinary shareholders, but do not provide executives with the full benefits of share ownership (such as dividend and voting rights) unless and until the performance rights vest. Details of the performance hurdle and the other terms applicable to the performance rights are summarised in the table below.

If Shareholder approval is obtained, it is intended that the performance rights will be granted to the Executive Directors within 3 years of the AGM.

If Shareholder approval is not obtained, the Board will need to consider alternative remuneration arrangements to appropriately remunerate and incentivise the Executive Directors.

Terms and conditions of performance rights granted under the Plan:

Executive Directors	Raimond Coneliano	Renato Coneliano	Richard Coneliano
Maximum long- term incentive (LTI) opportunity	$843,766	$317,638	$322,217
Performance Period	1 July 2025 to 30 June 2028
Initial Grant	421,883 performance rights	158,819 performance rights	161,108 performance rights
109349848 Formula for adjusting number of performance rights at end of Performance Period	Redox Limited Notice of Meeting 2023 At the end of the Performance Period, the Company will calculate the volume weighted average price (VWAP) of the Company’s shares traded on the ASX on the 5 trading days up to and including the date on which the performance hurdle is tested, rounded up to the nearest whole number of Rights and divide each Executive Director’s maximum LTI opportunity by this number. The resulting figure is known as the ‘Final Grant’. Each Executive Director’s Initial Grant will be increased or decreased to equal the Final Grant, which may involve lapsing performance rights for no consideration or issuing additional performance rights. The adjusted number of performance rights are called ‘Final Rights’. The Final Rights are then tested against the performance hurdle at the end of the Performance Period.

Page 8

109349848

Performance hurdles	The performance rights will be tested against the Company’s total shareholder return (TSR) relative to a comparator group over the Performance Period. The comparator group is the S&P/ASX 300 Index as at 1 July 2025 (Comparator Group). The following table sets out the percentage of performance rights that vest based on the Company’s TSR ranking over the Performance Period: Company TSR ranking in the Comparator Group Percentage of Final Rights that vest At or below the 50th percentile 0% Above the 50th percentile and below the 75th percentile straight-line pro rata basis between 0% and 100% At or above the 75th percentile 100% Following the end of the Performance Period, the Board will assess the extent to which the performance hurdle has been satisfied, and the Board will determine the relevant number (if any) of the participant’s Final Rights that will vest. Vesting is expected to occur on 31 August 2028. There is no retesting any performance rights that do not vest following testing will lapse unless the Board determines otherwise. Calculation of the performance hurdle and achievement against it will be determined by the Board in its absolute discretion, having regard to any matters that it considers relevant (including any adjustments for unusual or non-recurring items that the Board considers appropriate). The Board also has absolute discretion to adjust the Comparator Group to take into account events including, but not limited to, acquisitions, mergers or other relevant corporate actions or delisting.	The performance rights will be tested against the Company’s total shareholder return (TSR) relative to a comparator group over the Performance Period. The comparator group is the S&P/ASX 300 Index as at 1 July 2025 (Comparator Group). The following table sets out the percentage of performance rights that vest based on the Company’s TSR ranking over the Performance Period: Company TSR ranking in the Comparator Group Percentage of Final Rights that vest At or below the 50th percentile 0% Above the 50th percentile and below the 75th percentile straight-line pro rata basis between 0% and 100% At or above the 75th percentile 100% Following the end of the Performance Period, the Board will assess the extent to which the performance hurdle has been satisfied, and the Board will determine the relevant number (if any) of the participant’s Final Rights that will vest. Vesting is expected to occur on 31 August 2028. There is no retesting any performance rights that do not vest following testing will lapse unless the Board determines otherwise. Calculation of the performance hurdle and achievement against it will be determined by the Board in its absolute discretion, having regard to any matters that it considers relevant (including any adjustments for unusual or non-recurring items that the Board considers appropriate). The Board also has absolute discretion to adjust the Comparator Group to take into account events including, but not limited to, acquisitions, mergers or other relevant corporate actions or delisting.	The performance rights will be tested against the Company’s total shareholder return (TSR) relative to a comparator group over the Performance Period. The comparator group is the S&P/ASX 300 Index as at 1 July 2025 (Comparator Group). The following table sets out the percentage of performance rights that vest based on the Company’s TSR ranking over the Performance Period: Company TSR ranking in the Comparator Group Percentage of Final Rights that vest At or below the 50th percentile 0% Above the 50th percentile and below the 75th percentile straight-line pro rata basis between 0% and 100% At or above the 75th percentile 100% Following the end of the Performance Period, the Board will assess the extent to which the performance hurdle has been satisfied, and the Board will determine the relevant number (if any) of the participant’s Final Rights that will vest. Vesting is expected to occur on 31 August 2028. There is no retesting any performance rights that do not vest following testing will lapse unless the Board determines otherwise. Calculation of the performance hurdle and achievement against it will be determined by the Board in its absolute discretion, having regard to any matters that it considers relevant (including any adjustments for unusual or non-recurring items that the Board considers appropriate). The Board also has absolute discretion to adjust the Comparator Group to take into account events including, but not limited to, acquisitions, mergers or other relevant corporate actions or delisting.
Amount payable for performance rights	Performance rights are granted at no cost, and no amount is payable by participants on vesting of the performance rights.
Eligibility	At the discretion of the Board, the Company’s executive team are eligible to participate in the LTIP. Non-executive Directors are not eligible to participate in the LTIP.
Total remuneration package	Listing Rule 10.15.4 requires this Notice of Meeting to include details (including the amount) of the Executive Directors’ current total remuneration: Executive Directors:
	Raimond Coneliano	Renato Coneliano	Richard Coneliano
	• Total Fixed Remuneration (including superannuation) (TFR): $843,766 • Short term incentive: 100% of fixed remuneration • Long term incentive: maximum of 100% of the fixedremuneration	• TFR: $529,397 • Short term incentive: 50% of the fixed remuneration • Long term incentive: 60% of the fixed remuneration	• TFR: $429,623 • Short term incentive: 50% of fixed remuneration • Long term incentive: maximum of 75% of the fixed remuneration
	Shareholders are referred to the Company’s Remuneration Report for full details of Executive Director remuneration.
Vesting of performance rights	Each participant will receive one fully paid ordinary share in the Company for every vested performance right (subject toadjustments for capital actions in accordance with the Listing Rules and the Plan Rules). However, the Board, at its discretion, may determine to make an equivalent value cash payment to the participant in lieu of an allocation of shares.
109349848 Cessation of employment	Redox Limited Notice of Meeting 2023 Unless the Board determines otherwise, where: • the participant’s employment is terminated for cause or if they resign (or give notice of resignation) prior to vesting date, all of their unvested performance rights will lapse; or • the participant ceases employment for any other reason prior to the vesting date, all of the participant’s unvested performance rights will remain on foot and will be tested in the ordinary course as though the participant had not ceased employment.

Page 9

109349848

Malus/Claw back	Under the Plan Rules, the Company has the discretion to lapse unvested performance rights, and claw back vested shares or cash, in certain circumstances (such as dishonesty, fraud or gross misconduct). The Board has discretion to delay the vesting date, for example, to allow time for it to determine the appropriate outcome if there is an investigation underway by the Company or an external third party.
Voting and dividend rights	Performance rights do not carry any dividend or voting rights. Shares allocated on vesting of performance rights carry the same dividend and voting rights as other shares issued by the Company.
Change of control	The Board has discretion to vest or lapse the performance rights if there is a change of control.
Securities previously granted under the LTIP to the Executive Directors	In FY24 the following performance rights were issued to the Executive Directors for no cost: • Mr Raimond Coneliano: 350,000 of performance rights (Initial Grant), with a total maximum opportunity of $700,000. • Mr Renato Coneliano: 150,000 of performance rights (Initial Grant), with a total maximum opportunity of $300,000. • Mr Richard Coneliano: 150,000 of performance rights (Initial Grant), with a total maximum opportunity of $300,000. In FY25 the following performance rights were issued to the Executive Directors for no cost: • Mr Raimond Coneliano: 400,000 of performance rights (Initial Grant), with a total maximum opportunity of $800,000. • Mr Renato Coneliano: 150,000 of performance rights (Initial Grant), with a total maximum opportunity of $300,000. • Mr Richard Coneliano: 150,000 of performance rights (Initial Grant), with a total maximum opportunity of $300,000.
The terms of any loan in relation to the acquisition	No loans will be made in relation to the acquisition of performance rights.

Details of any performance rights issued under the LTIP will be published in the annual report of the Company relating to the period in which they were issued, along with a statement that approval for the issue was obtained under Listing Rule 10.14. Any additional persons covered by Listing Rule 10.14 who become entitled to participate in an issue of performance rights under the LTIP after Items 4.1, 4.2 and 4.3 are approved and who were not named in this Notice of Meeting, will not participate until approval is obtained under the rule.

A voting exclusion statement applies to the resolution of Items 4.1, 4.2 and 4.3, which is set out in the notes relating to voting.

Recommendation: The Board (with the Executive Directors abstaining) recommends that shareholders vote in favour of the resolution.

Redox Limited Notice of Meeting 2023

Page 10

109349848

Need assistance?

Phone:

1300 855 080 (within Australia) +61 3 9415 4000 (outside Australia)

Online:

www.investorcentre.com/contact

RDX

MR SAM SAMPLE FLAT 123 123 SAMPLE STREET THE SAMPLE HILL SAMPLE ESTATE SAMPLEVILLE VIC 3030

Redox Limited Annual General Meeting

The Redox Limited Annual General Meeting will be held on Wednesday, 8 October 2025 at 11:00am (AEDT). You are encouraged to participate in the meeting using the following options:

==> picture [47 x 47] intentionally omitted <==

MAKE YOUR VOTE COUNT

To lodge a proxy, access the Notice of Meeting and other meeting documentation visit www.investorvote.com.au and use the below information:

==> picture [38 x 38] intentionally omitted <==

Control Number: 999999 SRN/HIN: I9999999999 PIN: 99999

For Intermediary Online subscribers (custodians) go to www.intermediaryonline.com

For your proxy appointment to be effective it must be received by 11:00am (AEDT) on Monday, 6 October 2025.

==> picture [48 x 40] intentionally omitted <==

ATTENDING THE MEETING VIRTUALLY

To watch the webcast, ask questions and vote on the day of the meeting, please visit: https://meetnow.global/MSTNXNQ

For instructions refer to the online user guide www.computershare.com.au/virtualmeetingguide

==> picture [40 x 44] intentionally omitted <==

ATTENDING THE MEETING IN PERSON

The meeting will be held at:

Swissotel Sydney, 68 Market Street, Sydney, NSW 2000

You may elect to receive meeting-related documents, or request a particular one, in electronic or physical form and may elect not to receive annual reports. To do so, contact Computershare.

Samples/000001/000001

Need assistance?

Phone:

1300 855 080 (within Australia) +61 3 9415 4000 (outside Australia)

Online:

www.investorcentre.com/contact

RDX

MR SAM SAMPLE FLAT 123 123 SAMPLE STREET THE SAMPLE HILL SAMPLE ESTATE SAMPLEVILLE VIC 3030

YOUR VOTE IS IMPORTANT

For your proxy appointment to be effective it must be received by 11:00am (AEDT) on Monday, 6 October 2025.

Proxy Form

How to Vote on Items of Business

Lodge your Proxy Form:

XX

All your securities will be voted in accordance with your directions.

APPOINTMENT OF PROXY

Voting 100% of your holding: Direct your proxy how to vote by marking one of the boxes opposite each item of business. If you do not mark a box your proxy may vote or abstain as they choose (to the extent permitted by law). If you mark more than one box on an item your vote will be invalid on that item.

Voting a portion of your holding: Indicate a portion of your voting rights by inserting the percentage or number of securities you wish to vote in the For, Against or Abstain box or boxes. The sum of the votes cast must not exceed your voting entitlement or 100%.

Online:

Lodge your vote online at www.investorvote.com.au using your secure access information or use your mobile device to scan the personalised QR code.

Your secure access information is

Appointing a second proxy: You are entitled to appoint up to two proxies to attend the meeting and vote on a poll. If you appoint two proxies you must specify the percentage of votes or number of securities for each proxy, otherwise each proxy may exercise half of the votes. When appointing a second proxy write both names and the percentage of votes or number of securities for each in Step 1 overleaf.

Proxy voting by the Chair of the Meeting and members of the key management personnel (KMP): If you appoint a member of the Company's KMP or one of their closely related parties as your proxy, they will not be able to cast your votes on Items 2, 4.1, 4.2 and 4.3, unless you direct them how to vote, or the Chair of the Meeting is your proxy. If you appoint the Chair of the Meeting as your proxy, or the Chair of the Meeting becomes your proxy by default, and you do not mark a voting box for Items 2, 4.1, 4.2 or 4.3, then by submitting the Proxy Form you will be expressly authorising the Chair of the Meeting to vote in respect of the relevant Resolution even though it is connected with the remuneration of the Company's KMP.

==> picture [47 x 49] intentionally omitted <==

Control Number: 999999

SRN/HIN: I9999999999 PIN: 99999

For Intermediary Online subscribers (custodians) go to www.intermediaryonline.com

A proxy need not be a securityholder of the Company.

By Mail:

SIGNING INSTRUCTIONS FOR POSTAL FORMS

Individual: Where the holding is in one name, the securityholder must sign.

Computershare Investor Services Pty Limited GPO Box 242 Melbourne VIC 3001 Australia

Joint Holding: Where the holding is in more than one name, all of the securityholders should sign.

Power of Attorney: If you have not already lodged the Power of Attorney with the registry, please attach a certified photocopy of the Power of Attorney to this form when you return it.

Companies: Where the company has a Sole Director who is also the Sole Company Secretary, this form must be signed by that person. If the company (pursuant to section 204A of the Corporations Act 2001) does not have a Company Secretary, a Sole Director can also sign alone. Otherwise this form must be signed by a Director jointly with either another Director or a Company Secretary. Please sign in the appropriate place to indicate the office held. Delete titles as applicable.

PARTICIPATING IN THE MEETING

By Fax:

1800 783 447 within Australia or +61 3 9473 2555 outside Australia

PLEASE NOTE: For security reasons it is important that you keep your SRN/HIN confidential.

Corporate Representative

If a representative of a corporate securityholder or proxy is to participate in the meeting you will need to provide the appropriate “Appointment of Corporate Representative”. A form may be obtained from Computershare or online at www.investorcentre.com/au and select "Printable Forms".

Samples/000001/000002/i12

MR SAM SAMPLE FLAT 123 123 SAMPLE STREET THE SAMPLE HILL SAMPLE ESTATE SAMPLEVILLE VIC 3030

I ND

Change of address. If incorrect, mark this box and make the correction in the space to the left. Securityholders sponsored by a broker (reference number commences with ‘ X ’) should advise your broker of any changes.



I 9999999999

Proxy Form

Please mark

to indicate your directions

Step 1

Appoint a Proxy to Vote on Your Behalf

I/We being a member/s of Redox Limited hereby appoint the Chairman OR of the Meeting

XX

PLEASE NOTE: Leave this box blank if you have selected the Chairman of the Meeting. Do not insert your own name(s).

or failing the individual or body corporate named, or if no individual or body corporate is named, the Chairman of the Meeting, as my/our proxy to act generally at the meeting on my/our behalf and to vote in accordance with the following directions (or if no directions have been given, and to the extent permitted by law, as the proxy sees fit) at the Annual General Meeting of Redox Limited to be held at Swissotel Sydney, 68 Market Street, Sydney, NSW 2000 and online at https://meetnow.global/MSTNXNQ on Wednesday, 8 October 2025 at 11:00am (AEDT) and at any adjournment or postponement of that meeting.

Chairman of the Meeting authorised to exercise undirected proxies on remuneration related items: Where I/we have appointed the Chairman of the Meeting as my/our proxy (or the Chairman becomes my/our proxy by default), I/we expressly authorise the Chairman to exercise my/our proxy on Items 2, 4.1, 4.2 and 4.3 (except where I/we have indicated a different voting intention in step 2) even though Items 2, 4.1, 4.2 and 4.3 are connected directly or indirectly with the remuneration of a member of key management personnel, which includes the Chairman.

Important Note: If the Chairman of the Meeting is (or becomes) your proxy you can direct the Chairman to vote for or against or abstain from voting on Items 2, 4.1, 4.2 and 4.3 by marking the appropriate box in step 2.

Step 2 Items of Business

PLEASE NOTE: If you mark the Abstain box for an item, you are directing your proxy not to vote on your behalf on a poll and your votes will not be counted in computing the required majority.

For Against Abstain

Item	2	Adoption of the Remuneration Report
Item	3	Re-election of Director - Mary Verschuer
Item	4.1	Grant of Performance Rights to Raimond Coneliano
Item	4.2	Grant of Performance Rights to Renato Coneliano
Item	4.3	Grant of Performance Rights to Richard Coneliano

The Chairman of the Meeting intends to vote undirected proxies in favour of each item of business. In exceptional circumstances, the Chairman of the Meeting may change his/her voting intention on any item, in which case an ASX announcement will be made.

==> picture [535 x 97] intentionally omitted <==

----- Start of picture text -----

Step 3 Signature of Securityholder(s) This section must be completed.
Individual or Securityholder 1 Securityholder 2 Securityholder 3
/ /
Sole Director & Sole Company Secretary Director Director/Company Secretary Date
Update your communication details (Optional) By providing your email address, you consent to receive future Notice
Mobile Number Email Address of Meeting & Proxy communications electronically
----- End of picture text -----

3 1 9 0 4 4 A

R D X

RDXRM

MR RETURN SAMPLE 123 SAMPLE STREET SAMPLE SURBURB SAMPLETOWN VIC 3030

Dear Securityholder,

We have been trying to contact you at the above address in connection with your securityholding in Redox Limited. Unfortunately, our correspondence has been returned to us indicating that this is not the current address for you (i.e either marked “Unknown at the current address” and/or we have received a bounce back error for any email address on record). For security reasons we have flagged this against your securityholding which will exclude you from future mailings, other than notices of meeting.

Please note if you have previously elected to receive a hard copy Annual Report (including the financial report, directors’ report and auditor’s report) the dispatch of that report to you has been suspended but will be resumed on receipt of instructions from you to do so.

We value you as a securityholder and request that you supply your current address so that we can keep you informed about our Company. Where the correspondence has been returned to us in error we request that you advise us of this so that we may correct our records.

You are requested to include the following;

Securityholder Reference Number (SRN);

ASX trading code;

Name of company in which security is held;

Old address; and

New address.

Please ensure that the notification is signed by all holders and forwarded to our Share Registry at:

Computershare Investor Services Pty Limited GPO Box 2975 Melbourne Victoria 3001 Australia

Note: If your holding is sponsored within the CHESS environment you need to advise your sponsoring participant (in most cases this would be your broker) of your change of address so that your records with CHESS are also updated.

Yours sincerely

Redox Limited

Samples/000002/000005/i12